These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23200407)

  • 1. Prevalence estimates of diagnosed viral hepatitis B, liver condition outcomes and hospitalization costs: a population record-linkage study in Tayside, Scotland.
    McLernon DJ; Donnan PT; Dillon JF
    Epidemiol Infect; 2013 Oct; 141(10):2122-30. PubMed ID: 23200407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and economic burden of viral hepatitis: an observational population based study.
    Steinke DT; Weston TL; Morris AD; MacDonald TM; Dillon JF
    Gut; 2002 Jan; 50(1):100-5. PubMed ID: 11772975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of hepatitis B surface antigen seroreversion after corticosteroid treatment in patients with previous hepatitis B virus exposure.
    Wong GL; Wong VW; Yuen BW; Tse YK; Yip TC; Luk HW; Lui GC; Chan HL
    J Hepatol; 2020 Jan; 72(1):57-66. PubMed ID: 31499132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance.
    Ghisetti V; Marzano A; Zamboni F; Barbui A; Franchello A; Gaia S; Marchiaro G; Salizzoni M; Rizzetto M
    Liver Transpl; 2004 Mar; 10(3):356-62. PubMed ID: 15004761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and clinical relevance of occult hepatitis B in the fibrosis progression and antiviral response to INF therapy in HIV-HCV-coinfected patients.
    Laguno M; Larrousse M; Blanco JL; Leon A; Milinkovic A; Martínez-Rebozler M; Loncá M; Martinez E; Sanchez-Tapias JM; de Lazzari E; Gatell JM; Costa J; Mallolas J
    AIDS Res Hum Retroviruses; 2008 Apr; 24(4):547-53. PubMed ID: 18393687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
    Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
    Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral hepatitis prevalence in patients with active and latent tuberculosis.
    Nooredinvand HA; Connell DW; Asgheddi M; Abdullah M; O'Donoghue M; Campbell L; Wickremasinghe MI; Lalvani A; Kon OM; Khan SA
    World J Gastroenterol; 2015 Aug; 21(29):8920-6. PubMed ID: 26269682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
    Liao YP; Jiang JL; Zou WY; Xu DR; Li J
    World J Gastroenterol; 2015 Apr; 21(14):4284-92. PubMed ID: 25892880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B testing, care linkage, and vaccination coverage within a registry of hepatitis C infected patients.
    Harris AM; Millman AJ; Lora M; Osinubi A; Lom J; Miller LS
    Vaccine; 2019 Apr; 37(16):2188-2193. PubMed ID: 30902481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea].
    Boumbaly S; Balde TAL; Semenov AV; Ostankova YV; Serikova EN; Naidenova EV; Valutite DE; Shchemelev AN; Zueva EB; Esaulenko EV; Totolian AA
    Vopr Virusol; 2022 Mar; 67(1):59-68. PubMed ID: 35293189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tool to measure the economic impact of Hepatitis B elimination: A case study in Saudi Arabia.
    Sanai FM; Alghamdi M; Dugan E; Alalwan A; Al-Hamoudi W; Abaalkhail F; AlMasri N; Razavi-Shearer D; Razavi H; Schmelzer J; Alfaleh FZ
    J Infect Public Health; 2020 Nov; 13(11):1715-1723. PubMed ID: 32988769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational Therapy.
    Pan S; Yu Y; Wang S; Tu B; Shen Y; Qiu Q; Liu X; Su N; Zuo Y; Luan J; Zhang JY; Shi M; Meng F; Wang FS
    Front Immunol; 2022; 13():892618. PubMed ID: 35711409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins.
    Roche B; Roque-Afonso AM; Sebagh M; Delvart V; Duclos-Vallee JC; Castaing D; Samuel D
    Liver Transpl; 2010 Jul; 16(7):885-94. PubMed ID: 20583085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma.
    Wang F; Xu RH; Luo HY; Zhang DS; Jiang WQ; Huang HQ; Sun XF; Xia ZJ; Guan ZZ
    BMC Cancer; 2008 Apr; 8():115. PubMed ID: 18433487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group.
    Kim SJ; Hsu C; Song YQ; Tay K; Hong XN; Cao J; Kim JS; Eom HS; Lee JH; Zhu J; Chang KM; Reksodiputro AH; Tan D; Goh YT; Lee J; Intragumtornchai T; Chng WJ; Cheng AL; Lim ST; Suh C; Kwong YL; Kim WS
    Eur J Cancer; 2013 Nov; 49(16):3486-96. PubMed ID: 23910494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients.
    Lô G; Sow-Sall A; Diop-Ndiaye H; Mandiouba NC; Thiam M; Diop F; Ndiaye O; Gueye SB; Seck SM; Dioura AA; Mbow M; Gaye-Diallo A; Mboup S; Touré-Kâne C
    J Med Virol; 2016 Mar; 88(3):461-5. PubMed ID: 26252424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of sero-markers and non-invasive assessment of liver cirrhosis in patients with Hepatitis B virus infection in Freetown, Sierra Leone: a cross-sectional study.
    Lakoh S; Firima E; Jiba DF; Kamara MN; Gashau W; Deen GF; Adekanmbi O; Yendewa GA
    BMC Gastroenterol; 2021 Aug; 21(1):320. PubMed ID: 34372775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin.
    Deng L; Song Y; Young KH; Hu S; Ding N; Song W; Li X; Shi Y; Huang H; Liu W; Zheng W; Wang X; Xie Y; Lin N; Tu M; Ping L; Ying Z; Zhang C; Sun Y; Zhu J
    Oncotarget; 2015 Sep; 6(28):25061-73. PubMed ID: 26314957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and incidence rates of laboratory-confirmed hepatitis B infection in South Africa, 2015 to 2019.
    Moonsamy S; Suchard M; Pillay P; Prabdial-Sing N
    BMC Public Health; 2022 Jan; 22(1):29. PubMed ID: 34991533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent trends in hepatitis B virus infection in the general Korean population.
    Kim H; Shin AR; Chung HH; Kim MK; Lee JS; Shim JJ; Kim BH
    Korean J Intern Med; 2013 Jul; 28(4):413-9. PubMed ID: 23864799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.